127 related articles for article (PubMed ID: 37121554)
1. Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma.
Guan X; Lu Y; Zhang Y; Zhan P; Chen Z; Wang C; Yin Z
Immunol Lett; 2023 Jun; 258():8-19. PubMed ID: 37121554
[TBL] [Abstract][Full Text] [Related]
2. Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands.
Domaica CI; Fuertes MB; Rossi LE; Girart MV; Avila DE; Rabinovich GA; Zwirner NW
EMBO Rep; 2009 Aug; 10(8):908-15. PubMed ID: 19498463
[TBL] [Abstract][Full Text] [Related]
3. NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
Luci C; Bekri S; Bihl F; Pini J; Bourdely P; Nouhen K; Malgogne A; Walzer T; Braud VM; Anjuère F
PLoS One; 2015; 10(12):e0143224. PubMed ID: 26630176
[TBL] [Abstract][Full Text] [Related]
4. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
[TBL] [Abstract][Full Text] [Related]
5. NKp46
Pionnier N; Furlong-Silva J; Colombo SAP; Marriott AE; Chunda VC; Ndzeshang BL; Sjoberg H; Archer J; Steven A; Wanji S; Taylor MJ; Turner JD
Front Immunol; 2022; 13():969340. PubMed ID: 36238293
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Liu S; Yang L; Jia S; Zhao R; Jin Z
Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
[TBL] [Abstract][Full Text] [Related]
7. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
[TBL] [Abstract][Full Text] [Related]
8. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
[TBL] [Abstract][Full Text] [Related]
9. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
10. Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.
Berhani O; Glasner A; Kahlon S; Duev-Cohen A; Yamin R; Horwitz E; Enk J; Moshel O; Varvak A; Porgador A; Jonjic S; Mandelboim O
Eur J Immunol; 2019 Feb; 49(2):228-241. PubMed ID: 30536875
[TBL] [Abstract][Full Text] [Related]
11. NK cells suppress CD8
Chen T; Zhang T; Liu C; Wang C; Ding S; Shao Z; Fu R
Cell Immunol; 2019 Jan; 335():6-14. PubMed ID: 30471872
[TBL] [Abstract][Full Text] [Related]
12. Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.
Jost S; Reardon J; Peterson E; Poole D; Bosch R; Alter G; Altfeld M
Immunology; 2011 Apr; 132(4):516-26. PubMed ID: 21214542
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
[TBL] [Abstract][Full Text] [Related]
15. Expression of natural cytotoxicity receptor NKp46 on peripheral blood natural killer cells in women with a history of recurrent implantation failures.
Dons'koi BV; Osypchuk DV; Chernyshov VP; Khazhylenko KG
J Obstet Gynaecol Res; 2021 Mar; 47(3):1009-1015. PubMed ID: 33368832
[TBL] [Abstract][Full Text] [Related]
16. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.
Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA
Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413
[TBL] [Abstract][Full Text] [Related]
17. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
[TBL] [Abstract][Full Text] [Related]
18. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
[TBL] [Abstract][Full Text] [Related]
19. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
20. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP
J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
